State Action
CCAGW Urges Nevada Governor Joe Lombardo to Veto AB 259
AB 259 would allow price controls that would further distort the medical marketplace and fail to lower prices.
CCAGW Urges Oklahoma Senators to Sustain Governor Stitt's Veto of HB 2048
HB 2048 will change how the federal 340B Drug Discount Program operates in Oklahoma
CCAGW Urges Oklahoma Representatives to Sustain Governor Stitt's Veto of HB 2048
HB 2048 would change how the federal 340B Drug Discount Program operates in the Sooner State
CCAGW Urges Oklahoma Senators to Oppose HB 2048
HB 2048 would change how the federal 340B Drug Discount Program operates in the Sooner State.
CCAGW Urges Texas Representatives to Oppose HB 3265
HB 3265 would change how the federal 340B Drug Discount Program operates in the Lone Star State.
CCAGW Urges Colorado Legislators to Oppose SB 71
SB 71 would change how the federal 340B Drug Discount Program operates in Colorado.
CCAGW Urges Oregon Senators to Oppose HB 2385 A
HB 2385A would change how the federal 340B Drug Discount Program operates in Oregon.
CCAGW Urges Louisiana Legislators to Oppose HB 305
HB 305 would increase costs, delay deployment, and tilt the broadband deployment playing field toward government-owned networks.
CCAGW Urges Tennessee Governor Bill Lee to Veto SB 1414
SB 1414 would change how the federal 340B Drug Discount Program operates in Tennessee.
CCAGW Urges Oklahoma Senators to Oppose HB 2048
HB 2048 would change how the federal 340B Drug Discount Program operates in Oklahoma.
CCAGW Urges Oregon Legislators to Oppose Senate Bill 533
SB 533 would change how the federal 340B Drug Discount Program operates in Oregon.
CCAGW Urges Oregon Legislators to Oppose House Bill 2385
HB 2385 would change how the federal 340B Drug Discount Program operates in Oregon.
